Rakesh Jhunjhunwala-Backed Concord Biotech Files For IPO (Public Offer)
Wednesday, August 17, 2022
Comment
Upcoming IPO: Rare Enterprises-backed Concord Biotech has filed draft papers with the capital markets regulator SEBI to mop up funds through an initial public offering (IPO).
from NDTV Profit-Latest https://ift.tt/IEveiBJ
from NDTV Profit-Latest https://ift.tt/IEveiBJ
0 Response to "Rakesh Jhunjhunwala-Backed Concord Biotech Files For IPO (Public Offer)"
Post a Comment